Infinitt North America, an award-winning developer of enterprise imaging solutions for healthcare, today announced a partnership to market Lunit AI software, making it readily available to its North American customer base.

January 13, 2022 — Infinitt North America, an award-winning developer of enterprise imaging solutions for healthcare, today announced a partnership to market Lunit AI software, making it readily available to its North American customer base. Lunit recently received FDA 510 (k) clearance for Lunit Insight MMG, for detecting breast cancer, and Lunit CXR Triage, a Chest X-ray solution developed for sorting and prioritizing emergency cases. 

By partnering with Lunit, Infinitt can offer an enhanced integration with the AI solutions, enabling radiologists and ER clinicians to apply the algorithms and machine learning seamlessly, without any disruption in workflow.

Developed using Lunit’s deep learning technology, Lunit Insight MMG accurately analyses mammography images to detect lesions that could indicate breast cancer and provides location information for any detected lesions in the form of outlines and heatmaps. The computer-assisted diagnostic software has shown excellent performance in the early detection of breast cancer.

Lunit Insight CXR Triage chest detection suite accurately detects pre-specified suspected critical findings in chest X-ray's (pleural effusion and/or pneumothorax), quickly identifying critical conditions needing immediate attention. The algorithm performs at a 98-99% accuracy rate. 

David Smarro, President and CEO of Infinitt North America, is pleased to be partnering with a leading AI developer, marketing solutions that have already received FDA clearance. 

“Artificial Intelligence has so much potential in imaging informatics, both as a diagnostic tool and in getting all relevant patient data to the right clinician or subspecialist as quickly as possible. Earlier and more accurate diagnosis, earlier treatment, and a more patient-centered approach to care will improve clinical outcomes and reduce healthcare costs,” said Smarro.

With Lunit Insight MMG, rapid triage of screening mammograms will filter out benign cases for later evaluation, helping to reduce strain on radiologists as 60% of screening mammograms come up normal. 

For more information: www.infinittna.com/

 

 


Related Content

News | Ultrasound Imaging

Oct. 19, 2026 – GE HealthCare has introduced LOGIQ Focus, a new addition to its LOGIQ family of general imaging ...

Time October 19, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Women's Health

Oct. 15, 2026— SimBioSys has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of TumorSight Risk, its ...

Time October 19, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Oct. 8, 2026 — DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., has announced new findings published in ...

Time October 13, 2026
arrow
News | Breast Imaging

Oct. 6, 2026 — The American College of Radiology (ACR) has recognized Mercy Medical Center’s Tyanna O’Brien Center for ...

Time October 09, 2026
arrow
News | FDA

Oct.7, 2026 – MRI2CT Inc. has received FDA 510(k) clearance for NextMR, its AI powered imaging platform, for generating ...

Time October 07, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | Radiation Oncology

Sept. 23, 2026 — GE HealthCare has announced a new collaboration with a research team at Mass General Brigham to explore ...

Time October 02, 2026
arrow
Feature | Digital Pathology | Kyle Hardner

As recently as a decade ago, pathology technology was expected to become more expensive, larger and more precise. Yet in ...

Time October 02, 2026
arrow
News | Ultrasound Women's Health

Sept. 29, 2026 — A research team at the University of Virginia (UVA) led by Timothy Bullock, PhD, has published results ...

Time September 30, 2026
arrow
Subscribe Now